Navigation Links
Regeneron Reports Fourth Quarter and Full Year 2012 Financial and Operating Results
Date:2/14/2013

onciliations of these measures.

 Contacts Information:Michael Aberman, M.D.Peter DworkinInvestor RelationsCorporate Communications914.847.7799914.847.764michael.aberman@regeneron.competer.dworkin@regeneron.com 

TABLE 1REGENERON PHARMACEUTICALS, INC. CONDENSED BALANCE SHEETS (Unaudited)(In thousands)December 31,December 31,20122011ASSETSCash, restricted cash, and marketable securities$

587,511$

810,550Accounts receivable - trade, net593,20728,254Accounts receivable from Sanofi99,91374,781Deferred tax assets 340,156Property, plant, and equipment, net379,940367,955Other assets79,76342,043Total assets$

2,080,490$

1,323,583LIABILITIES AND STOCKHOLDERS' EQUITYAccounts payable, accrued expenses, and other liabilities$

118,604$

102,068Deferred revenue259,173300,250Facility lease obligations160,810160,514Convertible senior notes296,518275,019Stockholders' equity1,245,385485,732Total liabilities and stockholders' equity$

2,080,490$

1,323,583 

 TABLE 2REGENERON PHARMACEUTICALS, INC.CONDENSED STATEMENTS OF OPERATIONS (Unaudited)(In thousands, except per share data)Three months endedYear endedDecember 31,December 31,2012201120122011Revenues:Net product sales$

281,471$

29,752$

858,093$

44,686Sanofi collaboration revenue104,77977,032423,814326,609Bayer HealthCare collaboration revenue21,7919,37470,09943,072Technology licensing5,8925,89223,57124,858Contract research and other6699272,9006,599414,602122,9771,378,477445,824Expenses:Research and development181,024129,041625,554529,506Selling, general, and administrative57,73936,349210,755117,261Cost of goods sold30,1692,98984,4554,216268,932168,379920,764650,983Income (loss) from operations145,670(45,402)457,713(205,159)Other income (expense):Investment income3847992,01
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Regeneron Announces Receipt of Hart-Scott-Rodino Notice
2. Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
3. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
4. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
5. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
6. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
7. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
8. Regeneron Announces September 2012 Investor Conference Presentations
9. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
10. Regeneron Announces June 2012 Investor Conference Presentations
11. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , June 24, 2015 ... the addition of the "2015 Strategies in ... offering. This new 175-page report provides ... including diabetes (strips and meters), pregnancy, ovulation, and ... growth, regulatory requirements, technologies, and competitive profiles. ...
(Date:7/1/2015)... and FT LAUDERDALE, Florida , ... ("OrbusNeich"), a designer, developer, manufacturer and marketer of innovative medical ... on May 13, 2015, it prevailed in a final opposition ... Patent EP 1 341 482 - STENT HAVING HELICAL ELEMENTS ... review in the EPO and has been upheld as a ...
(Date:7/1/2015)... 2015 Dynatronics Corporation (the "Company") (NASDAQ: ... rehabilitation and physical therapy products, announced today that ... led by affiliates of Prettybrook Partners LLC (collectively, ... the healthcare industry. The financing provides Dynatronics with ... potential strategic acquisitions.  "We enthusiastically ...
Breaking Medicine Technology:2015 Strategies in the Home/Self Testing Market 2OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... Technologies, Inc. (NYSE Amex: PTN ) today announced ... Palatin,s request to begin a Phase 2A proof-of-concept human trial ... administered formulation of PL-3994, an NPR-A agonist compound, in development ... "We are excited about the prospect of advancing PL-3994 into ...
... 3, 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... preventive vaccines against cancers and infectious diseases, announced today that ... company overview at the ROTH 23rd Annual Growth Stock Conference ... A live and archived webcast will be accessible ...
Cached Medicine Technology:FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for Asthma 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 3
(Date:7/1/2015)... , ... July 01, 2015 , ... Summer recess has ... teenagers to fix noses and chins with plastic surgery when they’re looking for a ... more than 236,000 cosmetic procedures were performed on patients ages 19 and younger in ...
(Date:7/1/2015)... ... 2015 , ... As if mood swings, cramps and child labor weren’t enough ... leg pain. Northeast Houston Vein Center is offering tips on the treatment options for ... is underdiagnosed and often overlooked. Many women experience the tiredness, achiness, restless legs, cramps ...
(Date:7/1/2015)... Orange, NJ (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder in ... the National Scoliosis Foundation, it affects 2 to 3 percent of the population, or an ... scoliosis most often develops in children between the ages of 10 and 15. Most types ...
(Date:7/1/2015)... San Luis Obispo, CA (PRWEB) , ... July ... ... in non-surgical bunion treatment, announces their big summer sale. Customers purchasing two ... $15 with promo code "Summer15". , Bunion Bootie temporarily corrects misaligned ...
(Date:7/1/2015)... ... July 01, 2015 , ... After conducting a nationwide ... Tri-City Medical Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw as ... organization-wide compliance adaptation efforts and growing a focus on risk management, Bernard-Shaw will ...
Breaking Medicine News(10 mins):Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3
... women who are treated for estrogen-sensitive breast cancer quit ... The first study to actually ask the women ... rigorous study to examine the question -- reports 36 ... side effects, which are more severe and widespread than ...
... anti-bacterial additives in house paint are present in dangerous ... of Lausanne, says a study to be presented the ... conference in San Francisco. Chemicals engineered to kill microorganisms, ... to prevent molding and plant growth. Washed off of ...
... , FRIDAY, Dec. 9 (HealthDay News) -- ,Preschool children ... at increased risk for behavioral and emotional problems, new research ... of behavioral and emotional development tests on about 1,500 children ... 600 were full-term babies and nearly 1,000 were born between ...
... A new partnership between the Centre for Reviews and ... Health is launched today., PubMed Health is a new ... Information (NCBI) at the US National Library of Medicine ... provides summaries and full text of selected systematic reviews ...
... since the middle of 2011 as a treatment for ... benefit assessment pursuant to the "Act on the Reform ... Institute for Quality and Efficiency in Health Care (IQWiG) ... benefit in comparison with the previous standard therapy. According ...
... with a certain form of inherited hearing loss ... to a study by Professor Thomas Jentsch of ... for Molecular Medicine (MDC) Berlin-Buch and Professor Gary ... Madrid, Spain and Nijmegen, the Netherlands. The research ...
Cached Medicine News:Health News:Why women quit breast cancer drugs early 2Health News:Why women quit breast cancer drugs early 3Health News:Model shows how façade pollutants make it into the environment 2Health News:Behavior Problems May Surface in Preemies by Preschool 2Health News:Boceprevir: Indication of added benefit for specific patients 2Health News:Boceprevir: Indication of added benefit for specific patients 3Health News:People with DFNA2 hearing loss show increased touch sensitivity 2Health News:People with DFNA2 hearing loss show increased touch sensitivity 3
Straight shafts with 1 x 2 teeth. Serrated handle with polished finish. Delicate teeth....
Straight shafts with 0.12 mm teeth and 5 mm tying platform. Serrated handle with polished finish. Manufactured in titanium....
Angled 45 degree shafts with 0.5 teeth and 6 mm tying platform. Polished finish....
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Medicine Products: